Saini Sarbjit S
Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA.
Curr Allergy Asthma Rep. 2009 Jul;9(4):286-90. doi: 10.1007/s11882-009-0040-3.
Chronic urticaria is a common skin disease without an etiology in the majority of cases. The similarity of symptoms and pathology to allergen-induced skin reactions supports the idea that skin mast cell and blood basophil IgE receptor activation is involved; however, no exogenous allergen trigger has been identified. Recent evidence supports a role for blood basophils in disease expression. Specifically, blood basopenia is noted in active disease with the recruitment of blood basophils to skin lesional sites. In addition, blood basophils display altered IgE receptor-mediated degranulation that reverts in disease remission. In active chronic idiopathic urticaria (CIU) subjects, changes in IgE receptor-signaling molecule expression levels accompany the altered degranulation function in blood basophils. The arrival of therapies targeting IgE has further shown that altered blood basophil degranulation behavior has potential use as a disease biomarker in CIU.
慢性荨麻疹是一种常见的皮肤病,大多数病例无病因。其症状和病理与变应原诱导的皮肤反应相似,这支持了皮肤肥大细胞和血液嗜碱性粒细胞IgE受体激活参与其中的观点;然而,尚未确定外源性变应原触发因素。最近的证据支持血液嗜碱性粒细胞在疾病表现中起作用。具体而言,在活动性疾病中可观察到血液嗜碱性粒细胞减少,同时血液嗜碱性粒细胞被募集到皮肤病变部位。此外,血液嗜碱性粒细胞表现出IgE受体介导的脱颗粒改变,在疾病缓解时恢复正常。在活动性慢性特发性荨麻疹(CIU)患者中,IgE受体信号分子表达水平的变化伴随着血液嗜碱性粒细胞脱颗粒功能的改变。针对IgE的治疗方法的出现进一步表明,血液嗜碱性粒细胞脱颗粒行为的改变有可能作为CIU的疾病生物标志物。